Target
Metallo-beta-lactamase type 2
Ligand
BDBM360941
Substrate
n/a
Meas. Tech.
BIOLOGICAL ASSAYS
IC50
0.021±n/a nM
Citation
 Bennett, FJiang, JPasternak, ADong, SGu, XScott, JDTang, HZhao, ZHuang, YYang, DYoung, KXiao, LZhang, ZFu, J Metallo-beta-lactamase inhibitors US Patent  US10221163 Publication Date 3/5/2019 
Target
Name:
Metallo-beta-lactamase type 2
Synonyms:
B2 metallo-beta-lactamase | BLAN1_KLEPN | Beta-lactamase NDM-1 | Beta-lactamase type II | Metallo-beta-lactamase NDM-1 | Metallo-beta-lactamase type 2 | Metallo-beta-lactamase type II | NDM-1 | New Delhi metallo-beta-lactamase-1 | blaNDM-1
Type:
PROTEIN
Mol. Mass.:
28498.15
Organism:
Klebsiella pneumoniae
Description:
ChEMBL_103887
Residue:
270
Sequence:
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR
  
Inhibitor
Name:
BDBM360941
Synonyms:
3-(4-(2-amino- benzo[d]thiazol- 4-yl)-2-sulfamoyl-3- (1H-tetrazol-5-yl) phenylsulfonamido) quinuclidin- 1-ium 2,2,2- trifluoroacetate | US10221163, Example 97 | US10544130, Example 97
Type:
Small organic molecule
Emp. Form.:
C21H23N9O4S3
Mol. Mass.:
561.66
SMILES:
Nc1nc2c(cccc2s1)-c1ccc(c(c1-c1nnn[nH]1)S(N)(=O)=O)S(=O)(=O)NC1CN2CCC1CC2 |(-6.65,-1.33,;-5.88,-0,;-4.34,.16,;-4.02,1.67,;-2.69,2.44,;-2.69,3.98,;-4.02,4.75,;-5.36,3.98,;-5.36,2.44,;-6.5,1.41,;-1.36,1.67,;-1.36,.13,;-.02,-.64,;1.31,.13,;1.31,1.67,;-.02,2.44,;-.02,3.98,;1.22,4.88,;.75,6.35,;-.79,6.35,;-1.27,4.88,;2.64,2.44,;3.98,3.21,;3.98,1.67,;3.04,3.92,;2.64,-.64,;3.98,-1.41,;3.98,.13,;2.64,-2.18,;3.98,-2.95,;3.98,-4.49,;5.31,-5.26,;6.65,-4.49,;6.65,-2.95,;5.31,-2.18,;6.01,-3.4,;4.82,-4.09,)|
Structure:
Search PDB for entries with ligand similarity: